Clexane and Urinary incontinence - a phase IV clinical study of FDA data

Summary:

Urinary incontinence is reported as a side effect among people who take Clexane (enoxaparin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lyrica, and have Movement disorder.

The phase IV clinical study analyzes which people have Urinary incontinence when taking Clexane. It is created by eHealthMe based on reports of 14,633 people who have side effects when taking Clexane from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Urinary incontinence?

Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 1,632 drugs and 2,518 conditions by eHealthMe. Check the latest studies of Urinary incontinence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

14,633 people reported to have side effects when taking Clexane.
Among them, 45 people (0.31%) have Urinary incontinence.

Could Clexane cause Urinary incontinence?

Among these 45 people:

How long have people been on Clexane when they have Urinary incontinence? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Urinary incontinence when taking Clexane? *

  • female: 36.36 %
  • male: 63.64 %

What is the age of people who have Urinary incontinence when taking Clexane? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 2.86 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 34.29 %
  • 60+: 62.86 %

What are other drugs people take besides Clexane? *

  1. Lioresal: 12 people, 26.67%
  2. Lyrica: 12 people, 26.67%
  3. Vitamin B12: 11 people, 24.44%
  4. Gilenya: 11 people, 24.44%
  5. Amlodipine: 7 people, 15.56%
  6. Pradaxa: 7 people, 15.56%
  7. Movicol: 6 people, 13.33%
  8. Humira: 4 people, 8.89%
  9. Zestril: 3 people, 6.67%
  10. Melphalan Hydrochloride: 3 people, 6.67%

What are other side effects people have besides Urinary incontinence? *

  1. High Blood Pressure: 20 people, 44.44%
  2. Speech Impairment (Adult) (inability to speak (adult)): 18 people, 40.00%
  3. Spinal Osteoarthritis (joint cartilage loss in spine): 17 people, 37.78%
  4. Dyspnea (difficult or laboured breathing): 17 people, 37.78%
  5. Renal Cyst (kidney cyst): 17 people, 37.78%
  6. Weakness: 16 people, 35.56%
  7. Alanine Aminotransferase Increased: 15 people, 33.33%
  8. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 15 people, 33.33%
  9. Joint Pain: 14 people, 31.11%
  10. Gamma-Glutamyltransferase Increased: 14 people, 31.11%

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 24.44%
  2. Encephalomyelitis (inflammation of the brain and spinal cord): 11 people, 24.44%
  3. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 11 people, 24.44%
  4. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 10 people, 22.22%
  5. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 8 people, 17.78%
  6. Gait Disturbance: 8 people, 17.78%
  7. Asthma: 6 people, 13.33%
  8. High Blood Pressure: 4 people, 8.89%
  9. Multiple Myeloma (cancer of the plasma cells): 3 people, 6.67%
  10. Depression: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and have Urinary incontinence?

- Check whether Urinary incontinence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clexane:

Urinary incontinence treatments and more:

How severe was Urinary incontinence and when was it recovered:

Expand to all the drugs that have ingredients of enoxaparin sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clexane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary incontinence:

Browse all the conditions that are associated with Urinary incontinence:


How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Clexane) and Clexane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: